Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05843253
Title Study of Ribociclib and Everolimus in HGG and DIPG
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Nationwide Children's Hospital
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | NLD | GBR | DEU | CAN | AUS

Additional content available in CKB BOOST